Additional file 1 of The sustained PGE2 release matrix improves neovascularization and skeletal muscle regeneration in a hindlimb ischemia model

Additional file 1: Table S1. The sequences of human primers. Table S2. The sequences of mouse primers. Fig. S1. The PGE2 matrix promoted HUVECs proliferation in optimal concentration. Fig. S2. PGE2 release kinetics from the PGE2 matrix. Fig. S3. The time course of MyoD1 in ischemic muscle tissues treated with the PGE2 matrix. Fig. S4. PGE2 matrix ameliorated tissue injury in ischemic hindlimbs. Fig. S5. PGE2 matrix inhibited inflammatory responses and prevented apoptosis in vivo. Fig. S6. Images of the uncropped immunoblots shown in Fig. 7D. Boxes indicate cropped regions.